Skip to main content

News

Press Release
11/20/2019
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation (AF) has reaffirmed its commitment to tackling this new millennium epidemic by launching two major initiatives to...
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation (AF) has reaffirmed its commitment to tackling this new millennium epidemic by launching two major initiatives to...
Biosense Webster EMEA, a...
11/20/2019
EP Lab Digest
Press Release
11/20/2019
Baylis Medical announced the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world's first all-in-one left-heart access device featuring an atraumatic...
Baylis Medical announced the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world's first all-in-one left-heart access device featuring an atraumatic...
Baylis Medical announced the...
11/20/2019
EP Lab Digest
Press Release
11/20/2019
On November 18th, AF Association launched Global AF Aware Week 2019, an annual awareness week dedicated to raising awareness of atrial fibrillation (AF), the most commonly experienced arrhythmia, through our Detect, Protect, Correct, Perfect...
On November 18th, AF Association launched Global AF Aware Week 2019, an annual awareness week dedicated to raising awareness of atrial fibrillation (AF), the most commonly experienced arrhythmia, through our Detect, Protect, Correct, Perfect...
On November 18th, AF Association...
11/20/2019
EP Lab Digest
Press Release
11/18/2019
BioSig Technologies, Inc., a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intracardiac signals, announced that the Company...
BioSig Technologies, Inc., a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intracardiac signals, announced that the Company...
BioSig Technologies, Inc., a...
11/18/2019
EP Lab Digest
Press Release
11/18/2019
Wearable technology can safely identify heart rate irregularities that subsequent clinical evaluations confirmed to be atrial fibrillation, reports a study from the Stanford University School of Medicine and Apple now published in the New...
Wearable technology can safely identify heart rate irregularities that subsequent clinical evaluations confirmed to be atrial fibrillation, reports a study from the Stanford University School of Medicine and Apple now published in the New...
Wearable technology can safely...
11/18/2019
EP Lab Digest
Press Release
11/18/2019
The Bristol-Myers Squibb-Pfizer Alliance announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals). The study seeks to determine if...
The Bristol-Myers Squibb-Pfizer Alliance announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals). The study seeks to determine if...
The Bristol-Myers Squibb-Pfizer...
11/18/2019
EP Lab Digest
Press Release
11/18/2019
The American Heart Association (AHA) and the American College of Cardiology (ACC) jointly published new, 2019 AHA/ACC Clinical Performance and Quality Measures for Adults with High Blood Pressure in Circulation: Cardiovascular Quality and...
The American Heart Association (AHA) and the American College of Cardiology (ACC) jointly published new, 2019 AHA/ACC Clinical Performance and Quality Measures for Adults with High Blood Pressure in Circulation: Cardiovascular Quality and...
The American Heart Association...
11/18/2019
EP Lab Digest
Press Release
11/18/2019
Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, announced the presentation of new data from the SPECTRUM study evaluating Brinavess™ (vernakalant hydrochloride, IV), the Company's...
Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, announced the presentation of new data from the SPECTRUM study evaluating Brinavess™ (vernakalant hydrochloride, IV), the Company's...
Correvio Pharma Corp., a...
11/18/2019
EP Lab Digest
Press Release
11/18/2019
While intermittent fasting may sound like another dieting craze, the practice of routinely not eating and drinking for short periods of time has shown again to lead to potentially better health outcomes. In a new study by researchers at the...
While intermittent fasting may sound like another dieting craze, the practice of routinely not eating and drinking for short periods of time has shown again to lead to potentially better health outcomes. In a new study by researchers at the...
While intermittent fasting may...
11/18/2019
EP Lab Digest
Press Release
11/06/2019
Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered. Dr....
Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered. Dr....
Texas Heart Institute (THI) was...
11/06/2019
EP Lab Digest